Predicting Therapeutic Response to Neoadjuvant Immunotherapy Based on an Integration Model in Resectable Stage IIIA (N2) Non-Small Cell Lung Cancer
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY(2025)
Key words
neoadjuvant chemoimmunotherapy,non- small cell lung cancer,blood-based tumor mutational burden,deep learning,circulating tumor DNA
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined